Functional Assays
Coriolis Pharma offers comprehensive functional assay services to evaluate the biological activity and efficacy of your biopharmaceutical compounds. Our expert analytical scientists develop tailored methods to assess the critical quality attributes (CQAs) of your drug product, supporting formulation development and ensuring the functionality of your therapeutic compound throughout its shelf life.
Functional Assays Tailored to Your Needs
Coriolis provides a range of functional assay types customized to your product and development phase.
Our collaborative approach allows us to develop methods that precisely meet your requirements, including:
- Antibody binding affinity and specificity
- Infectivity and titer determination for viruses and viral vectors
- Ligand–receptor binding
We take a unique approach to method development, leveraging our broad scientific experience with diverse biopharmaceutical samples to tailor each assay to your specific needs.
Our functional assay services are performed under GMP conditions in dedicated labs with full quality oversight. These services can be applied to viruses, cells and viral vectors, and fall under biosafety level 2.
Functional Assay Methods
We can select the most suitable approach for your analytical challenge, whether following a standardized in-house workflow or a custom-tailored solution.
Analytical Method Development, Qualification and Validation
For common sample types, we can often apply standardized methods with little setup effort. However, when needed, our experienced analytical experts create or optimize custom methods tailored to your active pharmaceutical ingredient, product type and development phase.
Your Drug Product
Coriolis Pharma’s deep expertise across many biologic modalities, combined with input from world-leading external advisors, offers the knowledge and experience needed to solve even the most complex formulation and drug development challenges.
Your Phase
Our expert team has the expertise and experience to guide your biologics formulation development program from preclinical and early-phase development to the market.
Functional Assay Resources
Publications
April 12, 2024
Publications
Hyaluronan-Based Dissolving Microneedles with High Antigen Content for Intradermal Vaccination
January 1, 2019
Publications
October 24, 2017